Evaluation Of Visual Outcomes, Optical Quality, And Patient Satisfaction With A Novel Monofocal Intraocular Lens

To evaluate the visual acuity, contrast sensitivity, clinical safety and visual disturbances in patients implanted with 2 models of monofocal intraocular lenses (IOLs).

Patients without ocular comorbidities and corneal astigmatism less than 0.75 diopters (D) had cataract surgery with bilateral implantation of either of 2 monofocal IOLs, the Enova hydrophobic GF3 IOL or the Enova preloaded hydrophobic PGF3 IOL (VSY).

Twelve months postoperatively, monocular and binocular uncorrected and corrected distance visual acuities, as well as uncorrected (UIVA), distance corrected, and corrected intermediate and near visual acuities were measured.

A total of 208 eyes were included in this study. The mean CDVA of all eyes in this study improved from 0.44±0.42 logMAR pre operatively, to 0.05±0.11 logMAR post operatively (p <0.05). There were no statistically significant differences between the 2 groups in terms of photopic contrast sensitivity, glare and halo perception. The mean sphere and spherical equivalent values showed signifcant improvements (p <0.05) and (p <0.05). There were no intraoperative complications. The PGF3 IOL provided faster surgial procedure than GF3 IOL.

This study indicates excellent post-operative visual acuity, contrast sensitivity and refractive outcomes in eyes after Enova GF3 and Enova PGF3 implantation. This is associated with a low risk of intraoperative and postoperative complications.